It is common for CEOs and other insiders to schedule purchases at regular intervals. There is no conflict if it is done that way as long as the scheduled doesn’t conflict with an announcement, which they can discretely cancel the one purchase. Almost all bio techs I invest in, the CEOs and insiders do it all the time. As matter fact I do the same in my company. Not hard to do and remain compliant.
News 
Market Data 
Discover 
